| Site A | Site B | Site C |
---|---|---|---|
Number of IHD patients identified by electronic lipid reminders at each site | 720 | 1404 | 475 |
Proportion of IHD patients with electronic lipid reminders due for LDL measurement at beginning of study period | 27% | 19% | 21% |
Proportion of IHD patients with electronic lipid reminders due for LDL measurement at end of study period | 20% | 15% | 23% |
Proportion of patients with electronic lipid reminders due for lipid lowering treatment at beginning of study period | 10% | 14% | 11% |
Proportion of patients with electronic lipid reminders due for lipid lowering treatment at end of study period | 11% | 8% | 13% |